Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Hetzer Medical Indonesia Tbk. (MEDS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Hetzer Medical Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp228 (market cap 319B, 124.3K 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp72 (market cap 114.06B, 23.06M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 2.8× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (23.06M versus 124.3K). Which is the better fit depends on your goals.
| DGNS | MEDS | |
|---|---|---|
Market Cap | 319B | 114.06B |
Volume | 124.3K | 23.06M |
Lot | 1.24K | 230.55K |
Turnover | 28.28M | 1.68B |
Average Price | 227.48 | 72.75 |
Value | 28.28M | 1.68B |
Indicative Equilibrium Price | 228 | 72 |
Indicative Equilibrium Volume | 100 | 1.56K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Hetzer Medical Indonesia Tbk.
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →
